AllianceBernstein’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
JT
PA
BBA
OAG
AllianceBernstein's PRAX Position: Q2 2026 in Review
AllianceBernstein increased its Praxis Precision Medicines (PRAX) stake by 158% in Q2 2026, buying an estimated $13.9M and bringing the position to 71,518 shares worth $23M. The position accounts for 0.01% of the portfolio, ranked #865.
AllianceBernstein first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. The position peaked at $38.3M in Q4 2020. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- AllianceBernstein held 71,518 shares of Praxis Precision Medicines worth $23M as of Q2 2026.
- AllianceBernstein bought 43,818 Praxis Precision Medicines shares in Q2 2026, an estimated $13.9M.
- Praxis Precision Medicines made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #865 holding.
- AllianceBernstein first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
- AllianceBernstein's Praxis Precision Medicines position peaked at $38.3M in Q4 2020.
- 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.